Fonte: Journal of the American Society of Nephrology. Nome do evento: ASN Renal Week. Unidade: FM
Assuntos: ISQUEMIA (LESÃO), RIM (PATOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Benedito Jorge et al. Sirolimus (Siro) does not impair late recovery from acute renal dailure and prevents cycloporine A (CsA) aggravation of ischemia-reperfusion injury. Journal of the American Society of Nephrology. Washington: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 19 out. 2024. , 2002APA
Pereira, B. J., Castro, I., Burdmann, E. A., & Yu, L. (2002). Sirolimus (Siro) does not impair late recovery from acute renal dailure and prevents cycloporine A (CsA) aggravation of ischemia-reperfusion injury. Journal of the American Society of Nephrology. Washington: Faculdade de Medicina, Universidade de São Paulo.NLM
Pereira BJ, Castro I, Burdmann EA, Yu L. Sirolimus (Siro) does not impair late recovery from acute renal dailure and prevents cycloporine A (CsA) aggravation of ischemia-reperfusion injury. Journal of the American Society of Nephrology. 2002 ; 13 550A.[citado 2024 out. 19 ]Vancouver
Pereira BJ, Castro I, Burdmann EA, Yu L. Sirolimus (Siro) does not impair late recovery from acute renal dailure and prevents cycloporine A (CsA) aggravation of ischemia-reperfusion injury. Journal of the American Society of Nephrology. 2002 ; 13 550A.[citado 2024 out. 19 ]